David Cocke
Finanzdirektor/CFO bei TISSUE REGENIX GROUP PLC
Vermögen: 54 833 $ am 30.04.2024
Aktive Positionen von David Cocke
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TISSUE REGENIX GROUP PLC | Direktor/Vorstandsmitglied | 21.01.2021 | - |
Finanzdirektor/CFO | 21.01.2021 | - |
Karriereverlauf von David Cocke
Ehemalige bekannte Positionen von David Cocke
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
APERION BIOLOGICS, INC. | Finanzdirektor/CFO | 01.09.2008 | 01.01.2017 |
NUTECH, INC. | Finanzdirektor/CFO | 01.11.1993 | 01.05.1996 |
Kinetic Concepts, Inc.
Kinetic Concepts, Inc. Medical SpecialtiesHealth Technology Kinetic Concepts, Inc. develops advanced wound care solutions and therapies designed to deliver positive outcomes for patients and healthcare professionals. It operates business through two segments: Active Healing Solutions and LifeCell. The Active Healing Solutions segment is focused on the development and commercialization of advanced wound care therapies primarily based on its negative pressure technology platform. The LifeCell segment focuses on the development and commercialization of regenerative and reconstructive acellular tissue matrices for use in reconstructive, cosmetic, orthopedic and urogynecologic surgical procedures to repair soft tissue defects, as well as for reconstructive and cosmetic procedures. It has offices in Africa, Asia Pacific, Australia, Caribbean, Europe, Latin America, Middle East and North America. The company was founded by James R. Leininger in 1976 and is headquartered in San Antonio, TX. | Geschäftsführer | 01.01.1993 | 01.01.1996 |
Finanzdirektor/CFO | 01.01.1993 | 01.01.1996 | |
NuPak Medical Ltd.
NuPak Medical Ltd. Miscellaneous Commercial ServicesCommercial Services NuPak Medical Ltd. is an American company that specializes in the development of prototypes, testing, injection molding, and packaging services. The private company's focus is on providing these services to its clients. | Corporate Officer/Principal | - | - |
Ausbildung von David Cocke
The University of Texas at Austin | Undergraduate Degree |
University of Virginia Darden School of Business | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
Vereinigtes Königreich | 2 |
Operativ
Director of Finance/CFO | 4 |
Corporate Officer/Principal | 1 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
NUTECH, INC. | Commercial Services |
TISSUE REGENIX GROUP PLC | Health Technology |
Private Unternehmen | 3 |
---|---|
Kinetic Concepts, Inc.
Kinetic Concepts, Inc. Medical SpecialtiesHealth Technology Kinetic Concepts, Inc. develops advanced wound care solutions and therapies designed to deliver positive outcomes for patients and healthcare professionals. It operates business through two segments: Active Healing Solutions and LifeCell. The Active Healing Solutions segment is focused on the development and commercialization of advanced wound care therapies primarily based on its negative pressure technology platform. The LifeCell segment focuses on the development and commercialization of regenerative and reconstructive acellular tissue matrices for use in reconstructive, cosmetic, orthopedic and urogynecologic surgical procedures to repair soft tissue defects, as well as for reconstructive and cosmetic procedures. It has offices in Africa, Asia Pacific, Australia, Caribbean, Europe, Latin America, Middle East and North America. The company was founded by James R. Leininger in 1976 and is headquartered in San Antonio, TX. | Health Technology |
NuPak Medical Ltd.
NuPak Medical Ltd. Miscellaneous Commercial ServicesCommercial Services NuPak Medical Ltd. is an American company that specializes in the development of prototypes, testing, injection molding, and packaging services. The private company's focus is on providing these services to its clients. | Commercial Services |
Aperion Biologics, Inc.
Aperion Biologics, Inc. Medical DistributorsDistribution Services Aperion Biologics, Inc. engages in the development and implementation of its business plans, performing research on its platform technology, conducting clinical trials on its products in both animals and humans, pursuing regulatory approvals to market its product in U.S. and international markets, and raising capital. The firm's core platform technology is an enzymatic stripping of the key carbohydrate antigens followed by a unique conversion process that both humanizes and sterilizes the tissues without affecting their biomechanical or biological properties. The company was founded by Kevin Robert Stone in October 1996 and is headquartered in San Antonio, TX. | Distribution Services |
- Börse
- Insiders
- David Cocke
- Erfahrung